Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126079071 | 12607907 | 1 | I | 20160720 | 20160729 | 20160729 | EXP | US-LPDUSPRD-20160655 | LUITPOLD | FOX, LM.CO-ADMINISTRATION OF METHADONE AND ONDANSETRON ASSOCIATED WITH TORSADES DE POINTES .CLIN-TOXICOL - PHILA.2016;54(4):427. | 55.00 | YR | A | M | Y | 0.00000 | 20160729 | OT | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126079071 | 12607907 | 1 | PS | Ondansetron Injection (4420-01) | ONDANSETRON | 1 | Intravenous (not otherwise specified) | 4 MG THEN ANOTHER 4 MG | U | U | UNK | 79039 | INJECTION | ||||||
126079071 | 12607907 | 2 | SS | METHADONE | METHADONE HYDROCHLORIDE | 1 | Intramuscular | 10 MG | U | U | 0 |
Indications of drugs used
no results found |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
126079071 | 12607907 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126079071 | 12607907 | Drug interaction | |
126079071 | 12607907 | Electrocardiogram QT prolonged | |
126079071 | 12607907 | Torsade de pointes |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |